Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NNNN

Anbio Biotechnology

Feb 06 • 04:00PM ET

25.65

+1.59 6.61 %

Healthcare • Medical Instruments & Supplies • Germany • NASD

Feb 03, 12:02 PMRetail momentum in low-float stock amplified surge amid buzz over diagnostic product innovations.

Scroll to Statements

Index	-	P/E	405.85	EPS (ttm)	0.06	Insider Own	9.57%	Shs Outstand	43.89M	Perf Week	17.07%
Market Cap	3.69B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	39.69M	Perf Month	-25.11%
Enterprise Value	3.68B	PEG	-	EPS next Q	-	Inst Own	0.16%	Short Float	0.13%	Perf Quarter	16.59%
Income	2.82M	P/S	489.50	EPS this Y	-	Inst Trans	1.82%	Short Ratio	1.15	Perf Half Y	-44.30%
Sales	7.54M	P/B	34.81	EPS next Y	-	ROA	10.70%	Short Interest	0.05M	Perf YTD	-14.70%
Book/sh	0.74	P/C	234.19	EPS next 5Y	-	ROE	10.84%	52W High	55.65 -53.91%	Perf Year	-
Cash/sh	0.11	P/FCF	1640.36	EPS past 3/5Y	-5.05% -	ROIC	8.73%	52W Low	5.18 395.17%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	1894.35	Sales past 3/5Y	19.15% -	Gross Margin	89.72%	Volatility	33.07% 26.47%	Perf 5Y	-
Dividend TTM	-	EV/Sales	487.41	EPS Y/Y TTM	-42.91%	Oper. Margin	25.78%	ATR (14)	6.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	211.10	Sales Y/Y TTM	-26.65%	Profit Margin	37.47%	RSI (14)	46.86	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	211.10	EPS Q/Q	2.83%	SMA20	-11.09%	Beta	9.63	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-20.80%	SMA50	-15.45%	Rel Volume	0.72	Prev Close	24.06
Employees	27	LT Debt/Eq	0.00	Earnings	-	SMA200	-12.49%	Avg Volume	44.51K	Price	25.65
IPO	Feb 19, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	31,934	Change	6.61%

Jan-26-26 01:12PM	Stock Market Today: Trump's Medicare announcement slams health insurers (TheStreet) -24.73%
Aug-08-25 09:05PM	Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System (GlobeNewswire) +10.88% -7.89%
Jul-09-25 10:31AM	Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN) (Insider Monkey) +14.50%
Jul-04-25 06:00AM	The IPO market in 2025 is being driven by a clear theme bigger is better (Yahoo Finance)
May-15-25 01:05AM	Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions (GlobeNewswire) +6.12%
09:50AM	Loading…
Feb-20-25 09:50AM	Anbio Biotechnology Announces Closing of Initial Public Offering (GlobeNewswire)
Feb-18-25 06:10PM	Anbio Biotechnology Announces Pricing of Initial Public Offering (GlobeNewswire)

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NNNN

Anbio Biotechnology

Upgrade your FINVIZ experience